Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

Lifestyle Modification for Obesity

(2012) Thomas A. Wadden et al.   CIRCULATION

Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study

(2011) W Timothy Garvey et al.   AMERICAN JOURNAL OF CLINICAL NUTRITION

Cardiovascular safety of liraglutide assessed in a patient-level pooled analysis of phase 2—3 liraglutide clinical development studies

(2011) Steven P Marso et al.   Diabetes & Vascular Disease Research

Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide

(2011) A Astrup et al.   INTERNATIONAL JOURNAL OF OBESITY

Four-Year Weight Losses in the Look AHEAD Study: Factors Associated With Long-Term Success

(2011) Thomas A. Wadden et al.   Obesity

Feasibility and validation of a computer-automated Columbia-Suicide severity rating scale using interactive voice response technology

(2010) James C. Mundt et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Multicenter, Placebo-Controlled Trial of Lorcaserin for Weight Management

(2010) Steven R. Smith et al.   NEW ENGLAND JOURNAL OF MEDICINE

The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1-5 studies

(2009) L. Blonde et al.   DIABETES OBESITY & METABOLISM

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

(2009) Arne Astrup et al.   LANCET

Comparison of Strategies for Sustaining Weight LossThe Weight Loss Maintenance Randomized Controlled Trial

(2008) Laura P. Svetkey   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION